NVDA vs. DFTX
NVDA (NVIDIA Corporation) and DFTX (Definium Therapeutics, Inc) are both stocks. NVDA operates in Semiconductors (Technology), while DFTX operates in Biotechnology (Healthcare). Over the past 3 years, NVDA returned 71.13%/yr vs 87.91%/yr for DFTX. At a 0.24 correlation, their price movements are largely independent.
Performance
NVDA vs. DFTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVDA achieves a 10.16% return, which is significantly lower than DFTX's 84.84% return.
NVDA
- 1D
- 0.16%
- 1M
- -12.86%
- YTD
- 10.16%
- 6M
- 17.38%
- 1Y
- 44.72%
- 3Y*
- 71.13%
- 5Y*
- 63.13%
- 10Y*
- 67.95%
DFTX
- 1D
- 2.65%
- 1M
- 15.93%
- YTD
- 84.84%
- 6M
- 97.21%
- 1Y
- 245.19%
- 3Y*
- 87.91%
- 5Y*
- —
- 10Y*
- —
NVDA vs. DFTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
NVDA NVIDIA Corporation | 10.16% | 38.92% | 171.25% | 239.02% | -7.68% |
DFTX Definium Therapeutics, Inc | 84.84% | 92.39% | 90.16% | 66.36% | -78.74% |
Correlation
The correlation between NVDA and DFTX is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Jul 11, 2022 | 0.24 |
Fundamentals
NVDA:
$5.00T
DFTX:
$2.69B
NVDA:
$6.53
DFTX:
-$2.57
NVDA:
25.60
DFTX:
9.66
NVDA:
$253.49B
DFTX:
$0.00
NVDA:
$187.95B
DFTX:
$0.00
NVDA:
$192.76B
DFTX:
-$206.36M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVDA vs. DFTX — Risk / Return Rank
NVDA
DFTX
NVDA vs. DFTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for NVIDIA Corporation (NVDA) and Definium Therapeutics, Inc (DFTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVDA | DFTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.70 | ||
| Sortino ratioReturn per unit of downside risk | -2.17 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.46 | -0.25 |
| Calmar ratioReturn relative to maximum drawdown | 2.07 | 9.71 | -7.64 |
| Martin ratioReturn relative to average drawdown | 4.94 | 30.51 | -25.57 |
Loading charts...
Drawdowns
NVDA vs. DFTX - Drawdown Comparison
The maximum NVDA drawdown since its inception was -89.72%, roughly equal to the maximum DFTX drawdown of -86.01%. Use the drawdown chart below to compare losses from any high point for NVDA and DFTX.
Loading charts...
Drawdown Indicators
| NVDA | DFTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.72% | -86.01% | -3.71% |
Max Drawdown (1Y)Largest decline over 1 year | -20.21% | -24.79% | +4.58% |
Max Drawdown (3Y)Largest decline over 3 years | -36.88% | -58.38% | +21.50% |
Max Drawdown (5Y)Largest decline over 5 years | -66.34% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -66.34% | — | — |
Current DrawdownCurrent decline from peak | -12.86% | 0.00% | -12.86% |
Average DrawdownAverage peak-to-trough decline | -36.18% | -51.22% | +15.04% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.46% | 7.93% | +0.53% |
Volatility
NVDA vs. DFTX - Volatility Comparison
The current volatility for NVIDIA Corporation (NVDA) is 13.26%, while Definium Therapeutics, Inc (DFTX) has a volatility of 15.21%. This indicates that NVDA experiences smaller price fluctuations and is considered to be less risky than DFTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVDA | DFTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.26% | 15.21% | -1.95% |
Volatility (6M)Calculated over the trailing 6-month period | 26.67% | 38.79% | -12.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.00% | 61.83% | -26.83% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 51.76% | 83.94% | -32.18% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.84% | 83.94% | -34.10% |
Dividends
NVDA vs. DFTX - Dividend Comparison
NVDA's dividend yield for the trailing twelve months is around 0.14%, while DFTX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DFTX Definium Therapeutics, Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVDA NVIDIA Corporation | 0.14% | 0.02% | 0.03% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% |
Financials
NVDA vs. DFTX - Financials Comparison
This section allows you to compare key financial metrics between NVIDIA Corporation and Definium Therapeutics, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NVDA and DFTX have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DFTX has higher volatility (15.21%) compared to NVDA (13.26%). In terms of maximum drawdown, NVDA dropped -89.72% vs DFTX's -86.01%.
DFTX currently has the higher Sharpe Ratio (3.89 vs 1.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVDA and DFTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer